Heart transplantation an answer for end-stage heart failure.
Heart transplantation remains the best treatment option for end-stage heart failure. For patients who are not candidates for transplantation, better medical management and surgical options in heart failure can improve both the length and quality of a patient's life. Continuing research on xenotransplantation and the total artificial heart may decrease the need for human transplantation in years to come and may allow others with severe heart failure to have a chance at living longer.
Smith
Lanna
L
Medical University of South Carolina, 171 Astley Avenue, Charleston, SC 29425, USA. smithla@musc.edu
Farroni
Jennifer
J
Baillie
Barbara Ryan
BR
Haynes
Hwajoo
H
D000075202:Contraindications; D005544:Forecasting; D006333:Heart Failure / Q000453:epidemiology / Q000601:surgery*; D016027:Heart Transplantation / Q000379:methods / Q000639:trends; D006353:Heart-Assist Devices; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D018579:Patient Selection; D011300:Preoperative Care / Q000379:methods; D011379:Prognosis; D015996:Survival Rate; D014481:United States / Q000453:epidemiology; D014850:Waiting Lists